Viemed Healthcare (VMD) FCF Margin (2018 - 2026)

Viemed Healthcare's FCF Margin history runs 9 years deep, the most recent figure standing at 1.8% for Q1 2026.

• Quarterly FCF Margin rose 311.0% year-over-year to 1.8% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 18.86% (up 229.0% YoY) and the FY2025 annual result came in at 19.21%, up 222.0% from the prior year.
• FCF Margin was 1.8% for Q1 2026 at Viemed Healthcare, down from 30.47% in the prior quarter.
• Across five years, FCF Margin topped out at 65.79% in Q4 2024 and bottomed at 18.05% in Q3 2024.
• A 5-year average of 17.77% and a median of 17.98% in 2024 frame the typical range for FCF Margin.
• Annual changes were most pronounced in 2023 — FCF Margin sank 5633 bps — and 2025, when it jumped 6979 bps.
• Viemed Healthcare's FCF Margin stood at 18.89% in 2022, then soared by 213 bps to 59.22% in 2023, then grew by 11 bps to 65.79% in 2024, then sank by 54 bps to 30.47% in 2025, then tumbled by 94 bps to 1.8% in 2026.
• Business Quant data shows VMD's FCF Margin at 1.8% in Q1 2026, 30.47% in Q4 2025, and 51.74% in Q3 2025.